Medical News

RSS

KHN column: Why $75-a-day matters to caregivers

In his latest Kaiser Health News column, Howard Gleckman writes: "In the ongoing congressional debate over the CLASS Act—the proposed national long-term care insurance program—critics and supporters have been arguing over whether a benefit of $50- or even $75-a-day is worthwhile.

15 Dec 2009

Study shows elderly blacks more likely to skip medication compared to white counterparts

Older adults experience a number of medication-related problems, including under treatment, suboptimal drugs, suboptimal dosing, and non-adherence, which can have negative effects on their quality of life. Now new research, from the UNC Eshelman School of Pharmacy at the University of North Carolina at Chapel Hill shows that blacks have more medication-related problems than whites, and non-adherence to medical regimens is a particular issue for this group.

15 Dec 2009

Dyadic International enters into collaboration agreement with The Scripps Research Institute

Dyadic International, Inc. ("Dyadic") announced today that it has extended its collaboration with The Scripps Research Institute ("Scripps") by entering into an agreement with Scripps to re-annotate the genome of Dyadic's patented and proprietary C1 fungus ("C1").

15 Dec 2009

Varian Medical Systems introduces RapidArc radiotherapy technology in Finland

Cancer patients in Finland have gained access to more advanced treatments with the introduction of RapidArc® radiotherapy technology from Varian Medical Systems at the only private radiotherapy clinic in the Nordic region.

15 Dec 2009

ALS TDI and Applied Proteomics join to identify protein biomarkers associated with ALS

The ALS Therapy Development Institute (ALS TDI) and Applied Proteomics, Inc. announced today that they have completed the first stage of a multi-year collaboration to identify and validate protein biomarkers associated with amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease).

15 Dec 2009

HFA urges American Red Cross to end current labor issues over blood supply

The Hemophilia Federation of America (HFA) expresses its concern regarding the ongoing labor issues involving the Teamsters Local 929 and the American Red Cross of Pennsylvania /New Jersey.

15 Dec 2009

Medicare buy-in plan's cost may deter centrist lawmakers, potential customers

Some Democrats' idea to open Medicare to certain people aged 55 and older raises the question of whether premiums would be affordable enough.

15 Dec 2009

IOM issues review of national vaccine strategy

Reuters: To strengthen U.S. national vaccine strategy, the country "needs to establish a permanent group that advises the government on vaccine safety and spend more money to address safety concerns about vaccines," according to a report released Friday by the Institute of Medicine.

15 Dec 2009

Teva Pharmaceutical Industries receives approval for newly revised prescribing information for AZILECT

Teva Pharmaceutical Industries, Ltd. today announced the U.S. Food and Drug Administration (FDA) approved the newly revised prescribing information for AZILECT® (rasagiline tablets) reducing medication and food restrictions.

15 Dec 2009

Updated clinical data from Phase 2 study evaluating oral ridaforolimus presented

ARIAD Pharmaceuticals, Inc. today announced the presentation of updated clinical data from its Phase 2 study evaluating oral ridaforolimus in combination with trastuzumab (Herceptin®) in patients with resistant, metastatic breast cancer.

15 Dec 2009

Celebrex stops aspirin from doing its job effectively

Millions of Americans take Celebrex for arthritis or other pain. Many, if they are middle-aged or older, also take a low-dose aspirin tablet daily to reduce the risk of heart attack and stroke. Yet they may be getting little protection, because Celebrex keeps the aspirin from doing its job effectively, a new study suggests.

15 Dec 2009

NBC News examines 'fastest growing' vector-borne disease: Dengue

Dengue is the "fastest growing" vector-borne disease worldwide, NBC News' "World Blog" writes in a story examining the disease. "It used to be contained largely to south-east Asia, but has been spreading, and is now found in South America, Africa, south Asia and parts of Australia.

15 Dec 2009

Alexza Pharmaceuticals submits its NDA for Staccato loxapine to FDA

Alexza Pharmaceuticals, Inc. today announced that it has submitted its New Drug Application (NDA) for Staccato® loxapine (AZ-004) to the US Food and Drug Administration (FDA).

15 Dec 2009

Optiquant BKV Quantification Panel for MSSA DNA testing procedures

AcroMetrix, a leading provider of quality control standards for clinical diagnostic laboratories, announced today the launch of the first standardized quality control for MSSA molecular testing.

15 Dec 2009

Ted and Jane Von Voigtlander Foundation gifts $15 million to University of Michigan Health System

The University of Michigan Health System has received a $15 million gift from the Ted and Jane Von Voigtlander Foundation, the largest gift ever made to the Health System for women's health. It will support the construction of a new women's hospital.

15 Dec 2009

Brain plaques associated with increased risk of Alzheimer's disease

Scientists have long assumed that amyloid brain plaques found in autopsies of Alzheimer's patients are harmful and cause Alzheimer's disease. But autopsies of people with no signs of mental impairment have also revealed brain plaques, challenging this theory.

15 Dec 2009

Experts consider public option compromise, role of OPM in health bill

Kaiser Health News talks to nine experts who weigh in on the proposed public option compromise as a possible spinoff of the Federal Employee Health Benefits Program to be run by the Office of Personnel Management.

14 Dec 2009

Vion Pharmaceuticals receives complete response letter related to its NDA for Onrigin injection

VION PHARMACEUTICALS, INC. today announced that it had received a complete response letter from the U.S. Food and Drug Administration ("FDA") related to its New Drug Application ("NDA") for Onrigin(TM) (laromustine) injection submitted in February 2009.

14 Dec 2009

Boston Scientific completes public offering of $2 billion senior notes

Boston Scientific Corporation today announced the completion of a public offering of $2 billion aggregate principal amount of its senior notes under the Company's shelf registration statement.

14 Dec 2009

Senate approves appropriations package, Obama expected to sign

After the Senate approved a House-passed spending package worth almost $450 billion on Sunday, the legislation, which "includes annual foreign aid packages," will go to President Barack Obama, Agence France-Presse reports. Obama is expected to sign the legislation (12/13).

14 Dec 2009

Medical News

KHN column: Why $75-a-day matters to caregivers

Study shows elderly blacks more likely to skip medication compared to white counterparts

Dyadic International enters into collaboration agreement with The Scripps Research Institute

Varian Medical Systems introduces RapidArc radiotherapy technology in Finland

ALS TDI and Applied Proteomics join to identify protein biomarkers associated with ALS

HFA urges American Red Cross to end current labor issues over blood supply

Medicare buy-in plan's cost may deter centrist lawmakers, potential customers

IOM issues review of national vaccine strategy

Teva Pharmaceutical Industries receives approval for newly revised prescribing information for AZILECT

Updated clinical data from Phase 2 study evaluating oral ridaforolimus presented

Celebrex stops aspirin from doing its job effectively

NBC News examines 'fastest growing' vector-borne disease: Dengue

Alexza Pharmaceuticals submits its NDA for Staccato loxapine to FDA

Optiquant BKV Quantification Panel for MSSA DNA testing procedures

Ted and Jane Von Voigtlander Foundation gifts $15 million to University of Michigan Health System

Brain plaques associated with increased risk of Alzheimer's disease

Experts consider public option compromise, role of OPM in health bill

Vion Pharmaceuticals receives complete response letter related to its NDA for Onrigin injection

Boston Scientific completes public offering of $2 billion senior notes

Senate approves appropriations package, Obama expected to sign

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News